| GlaxoSmithKline AG - Requip-Modutab 2 mg, Tabletten mit veränderter Wirkstofffreisetzung | | 57740 | | 01 | | Requip-Modutab 2 mg | | Tabletten mit veränderter Wirkstofffreisetzung | | N04BC04 | | Ropinirole | | 06.11.2007 | | |
| | Composition | | ropinirolum 2 mg ut ropiniroli hydrochloridum, hypromellosum, lactosum monohydricum 46.32 mg, carmellosum natricum, ricini oleum hydrogenatum, maltodextrinum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, glyceroli dibehenas, mannitolum, povidonum K 29-32, magnesii stearas, silica colloidalis anhydrica, E 172 (flavum), Überzug: hypromellosum, macrogolum 400, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 1.6 mg. | | Packungsbestandteile | | | | | | | Active Agent | Dose |
|---|
| Ropinirol | 2 mg |
| | BAG: Active Agent | Dose |
|---|
| Ropinirol | 2 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | Carmellose Sodium | | | | | | color. | | | | color. | | | | | | Hypromellosum | | Überzug | | Lactose Monohydrate | 46.32 mg | | | Macrogol | 400 | | | | | | | Maltodextrine | | | | Mannitol | | | | | 29-32 | | | | | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 28 Tablet(s) | 17.76 | 35.65 | B | SL | No |
|
|
